|[April 08, 2014]
ECCRT, a SynteractHCR Company, Recognized as an Accredited Training Facility by TransCelerate BioPharma Inc.
SAN DIEGO --(Business Wire)--
The European Centre for Clinical Research Training (ECCRT),
company, has been recognized by TransCelerate BioPharma Inc. as an
official training facility that meets the standards established for
investigator training by this association of biopharma companies.
TransCelerate BioPharma Inc. is a non-profit organization focused on
advancing innovation in research and development (R&D), identifying and
solving common R&D challenges, and further improving patient safety,
with the goal of delivering more high quality medicines to patients. It
has established several clinical data standards, including study site
qualification and training. Once accredited by the organization, ECCRT
is recognized by all members of the organization as an approved
training facility for investigators - which in turn, means that all
investigators trained by this facility meet the standards established.
"SynteractHCR and its training facility are dedicated to supporting even
higher levels of proficiency in the industry," says Gerald Van Roey,
M.Ph.Ed., managing director at ECCRT. "To achieve this end, it was
imperative for us to be acknowledged as an industry-recognized site for
investigator training. Training is an important investment for
companies, and one that will pay off in the long-run, in having both
more engaged employees and better patient care."
TransCelerate evolved from discussions at various forums for executive
R&D leadership to discuss relevant issues facing the industry and
solutions for addressing common challenges. SynteractHCR supports the
goal of this organization to enhance focus on qualitative training based
on good course design, correct methodology and Good Clinical Practice.
As part of its ICD+ initiative, SynteractHCR seeks out ways to increase
efficiencies, streamline process and improve outcomes; ECCRT's
recognition by TransCelerate meets the goals of the organization as well
as that of its parent company.
About SynteractHCR (www.synteracthcr.com)
SynteractHCR is a full-service contract research organization with a
successful two-decade track record supporting biotechnology, medical
device and pharmaceutical companies in all phases of clinical
development. SynteractHCR has conducted Phase I-IV studies on six
continents and in more than 50 countries, offering expertise across
multiple therapeutic areas and with notable depth in oncology, CNS,
infectious disease, endocrinology, cardiovascular and respiratory, among
other indications. With its "Shared Work - Shared Vision" philosophy and
ICD+ approach, SynteractHCR provides customized services collaboratively
and cost effectively, ensuring on-time delivery of quality data so
clients get to decision points faster.
[ Back To TMCnet.com's Homepage ]